Maryland researchers receive $2.5 million grant to develop a Shigella, E. coli vaccine
by Press Release from Outbreak News Today on (#2YF5T)
The University of Maryland School of Medicine (UM SOM) has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal disease in young children in developing countries and a common cause ["]
The post Maryland researchers receive $2.5 million grant to develop a Shigella, E. coli vaccine appeared first on Outbreak News Today.